Innovative Technologies to Non-Invasively Monitor Genome Edited Cells In Vivo (UH2/UH3)
| קרן | National Institutes of Health (NIH) |
|---|---|
| מדינה | U.S.A. |
| סוג | Research Grants |
| תאריך אחרון | 18/10/2018 |
| פקולטה | Engineering, Life Sciences, Medicine |
| תיאור | The purpose of this grant is to support the development of innovative technologies to non-invasively label and monitor genome edited cells in vivo. The ultimate goal for these technologies is to inform on safety and efficacy of in vivo genome editing over time.
Funding: UH2 $150,000 per year (2 years) UH3 $300,000 per year (2 years) Duration: 4 years
Research Authority due date: 6.9.18 LOI (encourged) due date: 18.9.18
|
| קבצים מצורפים | |
| קישור | לאתר |
| עדכון אחרון | עדכון אחרון: 26/07/2018 |
